Logo image of 1CLSK.MI

CLEANSPARK INC (1CLSK.MI) Stock Fundamental Analysis

BIT:1CLSK - Euronext Milan - US18452B2097 - Common Stock - Currency: EUR

8.834  +8.83 (+Infinity%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1CLSK. 1CLSK was compared to 102 industry peers in the Software industry. The financial health of 1CLSK is average, but there are quite some concerns on its profitability. 1CLSK is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year 1CLSK has reported negative net income.
In the past year 1CLSK has reported a negative cash flow from operations.
In the past 5 years 1CLSK always reported negative net income.
1CLSK had negative operating cash flow in 4 of the past 5 years.
1CLSK.MI Yearly Net Income VS EBIT VS OCF VS FCF1CLSK.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

1CLSK has a worse Return On Assets (-7.36%) than 66.67% of its industry peers.
1CLSK has a Return On Equity of -10.34%. This is in the lower half of the industry: 1CLSK underperforms 64.71% of its industry peers.
Industry RankSector Rank
ROA -7.36%
ROE -10.34%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
1CLSK.MI Yearly ROA, ROE, ROIC1CLSK.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 51.98%, 1CLSK is not doing good in the industry: 63.73% of the companies in the same industry are doing better.
1CLSK's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for 1CLSK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
1CLSK.MI Yearly Profit, Operating, Gross Margins1CLSK.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

1CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1CLSK has been increased compared to 1 year ago.
Compared to 5 years ago, 1CLSK has more shares outstanding
Compared to 1 year ago, 1CLSK has a worse debt to assets ratio.
1CLSK.MI Yearly Shares Outstanding1CLSK.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1CLSK.MI Yearly Total Debt VS Total Assets1CLSK.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

1CLSK has an Altman-Z score of 2.50. This is not the best score and indicates that 1CLSK is in the grey zone with still only limited risk for bankruptcy at the moment.
1CLSK has a Altman-Z score of 2.50. This is comparable to the rest of the industry: 1CLSK outperforms 48.04% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that 1CLSK is not too dependend on debt financing.
1CLSK has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.5
ROIC/WACCN/A
WACC8.94%
1CLSK.MI Yearly LT Debt VS Equity VS FCF1CLSK.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

1CLSK has a Current Ratio of 8.67. This indicates that 1CLSK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.67, 1CLSK belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
A Quick Ratio of 8.67 indicates that 1CLSK has no problem at all paying its short term obligations.
1CLSK has a Quick ratio of 8.67. This is amongst the best in the industry. 1CLSK outperforms 96.08% of its industry peers.
Industry RankSector Rank
Current Ratio 8.67
Quick Ratio 8.67
1CLSK.MI Yearly Current Assets VS Current Liabilites1CLSK.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

1CLSK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -222.22%.
The Revenue has grown by 89.48% in the past year. This is a very strong growth!
1CLSK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.70% yearly.
EPS 1Y (TTM)-222.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.48%
Revenue 1Y (TTM)89.48%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%62.53%

3.2 Future

Based on estimates for the next years, 1CLSK will show a very strong growth in Earnings Per Share. The EPS will grow by 163.11% on average per year.
Based on estimates for the next years, 1CLSK will show a very strong growth in Revenue. The Revenue will grow by 45.45% on average per year.
EPS Next Y1439.62%
EPS Next 2Y303.47%
EPS Next 3Y163.11%
EPS Next 5YN/A
Revenue Next Year92.59%
Revenue Next 2Y66.47%
Revenue Next 3Y45.45%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1CLSK.MI Yearly Revenue VS Estimates1CLSK.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
1CLSK.MI Yearly EPS VS Estimates1CLSK.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1CLSK. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 8.92, which indicates a very decent valuation of 1CLSK.
Based on the Price/Forward Earnings ratio, 1CLSK is valued cheaper than 94.12% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, 1CLSK is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.92
1CLSK.MI Price Earnings VS Forward Price Earnings1CLSK.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1CLSK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.56
1CLSK.MI Per share data1CLSK.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CLSK's earnings are expected to grow with 163.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y303.47%
EPS Next 3Y163.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1CLSK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

BIT:1CLSK (6/11/2025, 7:00:00 PM)

8.834

+8.83 (+Infinity%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners62.29%
Inst Owner ChangeN/A
Ins Owners2.28%
Ins Owner ChangeN/A
Market Cap2.48B
Analysts82.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-4.08%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-153.14%
Min EPS beat(2)-403.92%
Max EPS beat(2)97.65%
EPS beat(4)1
Avg EPS beat(4)-174.62%
Min EPS beat(4)-403.92%
Max EPS beat(4)97.65%
EPS beat(8)4
Avg EPS beat(8)35.95%
EPS beat(12)6
Avg EPS beat(12)3.83%
EPS beat(16)6
Avg EPS beat(16)-62.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)4.69%
Revenue beat(4)1
Avg Revenue beat(4)-2.98%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)4.69%
Revenue beat(8)3
Avg Revenue beat(8)-1.1%
Revenue beat(12)4
Avg Revenue beat(12)-2.59%
Revenue beat(16)4
Avg Revenue beat(16)-6.64%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.92
P/S 5.31
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.63
EV/EBITDA 23.56
EPS(TTM)-0.25
EYN/A
EPS(NY)0.99
Fwd EY11.21%
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS1.66
BVpS5.85
TBVpS5.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.36%
ROE -10.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.98%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score1
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 4.45
Cap/Depr 85.18%
Cap/Sales 37.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.67
Quick Ratio 8.67
Altman-Z 2.5
F-Score1
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-222.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.48%
EPS Next Y1439.62%
EPS Next 2Y303.47%
EPS Next 3Y163.11%
EPS Next 5YN/A
Revenue 1Y (TTM)89.48%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%62.53%
Revenue Next Year92.59%
Revenue Next 2Y66.47%
Revenue Next 3Y45.45%
Revenue Next 5YN/A
EBIT growth 1Y-47.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year994.95%
EBIT Next 3Y134.9%
EBIT Next 5YN/A
FCF growth 1Y-2529.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1149.55%
OCF growth 3YN/A
OCF growth 5YN/A